| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Immunic Inc (NASDAQ: IMUX)
IMUX Technical Analysis
5
| As on 9th Jun 2023 IMUX STOCK Price closed @ 1.72 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.85 & Strong Sell for SHORT-TERM with Stoploss of 11.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMUXSTOCK Price
| Open | 1.75 | Change | Price | % |
| High | 1.83 | 1 Day | -0.08 | -4.44 |
| Low | 1.69 | 1 Week | 0.07 | 4.24 |
| Close | 1.72 | 1 Month | 0.06 | 3.61 |
| Volume | 394900 | 1 Year | -8.25 | -82.75 |
| 52 Week High 14.26 | 52 Week Low 1.13 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IMUX Daily Charts |
IMUX Intraday Charts |
Whats New @ Bazaartrend |
IMUX Free Analysis |
|
|
IMUX Important Levels Intraday
| RESISTANCE | 1.99 |
| RESISTANCE | 1.90 |
| RESISTANCE | 1.85 |
| RESISTANCE | 1.80 |
| SUPPORT | 1.64 |
| SUPPORT | 1.59 |
| SUPPORT | 1.54 |
| SUPPORT | 1.45 |
IMUX Forecast May 2024
| 4th UP Forecast | 11.82 |
| 3rd UP Forecast | 8.58 |
| 2nd UP Forecast | 6.58 |
| 1st UP Forecast | 4.58 |
| 1st DOWN Forecast | -1.14 |
| 2nd DOWN Forecast | -3.14 |
| 3rd DOWN Forecast | -5.14 |
| 4th DOWN Forecast | -8.38 |
IMUX Weekly Forecast
| 4th UP Forecast | 5.50 |
| 3rd UP Forecast | 4.29 |
| 2nd UP Forecast | 3.54 |
| 1st UP Forecast | 2.79 |
| 1st DOWN Forecast | 0.65 |
| 2nd DOWN Forecast | -0.10 |
| 3rd DOWN Forecast | -0.85 |
| 4th DOWN Forecast | -2.06 |
IMUX Forecast2024
| 4th UP Forecast | 27.52 |
| 3rd UP Forecast | 19.25 |
| 2nd UP Forecast | 14.13 |
| 1st UP Forecast | 9.02 |
| 1st DOWN Forecast | -5.58 |
| 2nd DOWN Forecast | -10.69 |
| 3rd DOWN Forecast | -15.81 |
| 4th DOWN Forecast | -24.08 |
Immunic Inc ( NASDAQ USA Symbol : IMUX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMUX Business Profile
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York. Address: 1200 Avenue of the Americas, New York, NY, United States, 10036
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service